Irena Selicharová
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Irena Selicharová has a total of 129 co-authors. Here are the top co-authors by number of shared publications:
- Jiří Jiráček
Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Flemingovo nám.2, Prague 6, 16000, Czech Republic
16 shared publications - Lenka Žáková
Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Flemingovo n. 2, 16000 Praha 6, Czech Republic
7 shared publications - Martina Chrudinová
Biology Department, Boston College , Chestnut Hill, MA
5 shared publications - Miloslav Sanda
Max‐Planck‐Institut fuer Herz‐ und Lungenforschung Bad Nauheim Germany
5 shared publications Marek Kořínek
3 shared publications- Marta Lubos
Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Flemingovo nám.2, Prague 6, 16000, Czech Republic
3 shared publications
Latest Publications
- Open Access
Synthetic inhibitors of pregnancy-associated plasma protein-A regulate IGF-1 signaling in vitro and in vivo
Dysregulation of insulin-like growth factor (IGF) signaling contributes to diverse human diseases. Therapeutic strategies have largely targeted the IGF-1 receptor, but the complexity of the IGF system has limited their clinical efficacy. Pregnancy-associated plasma protein-A (PAPP-A) is a secreted metalloproteinase that regulates local IGF signaling through proteolytic cleavage of IGF-binding proteins (IGFBPs) and represents an attractive therapeutic target. Here, we report the first synthetic PAPP-A inhibitors designed to target the enzyme active site using an IGFBP-5-derived anchor sequence. Replacing the scissile bond with phosphinate or phosphonate moieties yielded potent and selective PAPP-A inhibitors. Cryo-electron microscopy revealed the molecular basis of inhibition and key active-site interactions. The compounds inhibited cleavage of IGFBP-4 and IGFBP-5, two physiological PAPP-A substrates. They suppressed IGF-1 signaling in A549 lung cancer cells, with efficacy comparable to the endogenous PAPP-A inhibitor stanniocalcin-1. They also inhibited Papp-aa-dependent IGF signaling and cell proliferation in wild-type and stc1a-/- mutant zebrafish in vivo in a dose-dependent manner. Together, these findings establish the first class of synthetic, selective PAPP-A inhibitors capable of modulating IGF signaling. They provide new chemical tools for studying and modulating pathological IGF signaling and offer new directions for developing PAPP-A-targeted therapeutic strategies.
Open AccessSynthetic inhibitors of pregnancy-associated plasma protein-A regulate IGF-1 signaling in vitro and in vivo
Dysregulation of insulin-like growth factor (IGF) signaling contributes to diverse human diseases. Therapeutic strategies have largely targeted the IGF-1 receptor, but the complexity of the IGF system has limited their clinical efficacy. Pregnancy-associated plasma protein-A (PAPP-A) is a secreted metalloproteinase that regulates local IGF signaling through proteolytic cleavage of IGF-binding proteins (IGFBPs) and represents an attractive therapeutic target. Here, we report the first synthetic PAPP-A inhibitors designed to target the enzyme active site using an IGFBP-5-derived anchor sequence. Replacing the scissile bond with phosphinate or phosphonate moieties yielded potent and selective PAPP-A inhibitors. Cryo-electron microscopy revealed the molecular basis of inhibition and key active-site interactions. The compounds inhibited cleavage of IGFBP-4 and IGFBP-5, two physiological PAPP-A substrates. They suppressed IGF-1 signaling in A549 lung cancer cells, with efficacy comparable to the endogenous PAPP-A inhibitor stanniocalcin-1. They also inhibited Papp-aa-dependent IGF signaling and cell proliferation in wild-type and stc1a-/- mutant zebrafish in vivo in a dose-dependent manner. Together, these findings establish the first class of synthetic, selective PAPP-A inhibitors capable of modulating IGF signaling. They provide new chemical tools for studying and modulating pathological IGF signaling and offer new directions for developing PAPP-A-targeted therapeutic strategies.
- Open Access
- 29 July 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Conformational changes in insulin receptor illuminated by live-cell linear dichroism imaging and a FLIP biosensor
Insulin receptor (IR) is a tyrosine kinase involved in vital cellular signaling processes related to glucose metabolism and cell growth. Detailed understanding of molecular mechanisms of IR signaling is important for improved treatments of diabetes and related disorders. Although many aspects of IR signaling have over the past years been elucidated, much of the available information comes from studies made in vitro, using protein preparations. However, observations performed directly in living cells, tissues and organisms are needed for proper understanding of IR signaling. To address this need, we decided to investigate GP2(1)-eGFP-CD59, a recently identified FLIP biosensor of IR conformation that takes advantage of the powerful yet underutilized technique of linear dichroism fluorescence microscopy. Our approach allowed us to detect, in living cells, changes in the IR ectodomain in response to IR agonists and inhibitors. Surprisingly, we observed rearrangements in the ectodomain even upon administering an IR kinase inhibitor. Our findings suggest that the state of the intracellular kinase domain plays a role in the stability/conformation of the ectodomain, and urge caution in using solely the ectodomain in structural studies. Furthermore, our results open doors to sensitive imaging of various aspects of IR function in living cells, tissues, and ultimately whole organisms, under conditions close to natural.
- 29 July 2026
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Open AccessConformational changes in insulin receptor illuminated by live-cell linear dichroism imaging and a FLIP biosensor
Insulin receptor (IR) is a tyrosine kinase involved in vital cellular signaling processes related to glucose metabolism and cell growth. Detailed understanding of molecular mechanisms of IR signaling is important for improved treatments of diabetes and related disorders. Although many aspects of IR signaling have over the past years been elucidated, much of the available information comes from studies made in vitro, using protein preparations. However, observations performed directly in living cells, tissues and organisms are needed for proper understanding of IR signaling. To address this need, we decided to investigate GP2(1)-eGFP-CD59, a recently identified FLIP biosensor of IR conformation that takes advantage of the powerful yet underutilized technique of linear dichroism fluorescence microscopy. Our approach allowed us to detect, in living cells, changes in the IR ectodomain in response to IR agonists and inhibitors. Surprisingly, we observed rearrangements in the ectodomain even upon administering an IR kinase inhibitor. Our findings suggest that the state of the intracellular kinase domain plays a role in the stability/conformation of the ectodomain, and urge caution in using solely the ectodomain in structural studies. Furthermore, our results open doors to sensitive imaging of various aspects of IR function in living cells, tissues, and ultimately whole organisms, under conditions close to natural.
- Open Access
- 27 May 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Expedient single-round selection of hyper-modified aptamer targeting insulin receptor from over-represented dually nucleobase-modified DNA libraries
Discovery of functional nucleic acids from randomized libraries typically relies on multiple, time-consuming iterative rounds of in vitro selection with low success rate. Here, we present a single-round selection strategy for rapid screening of multiple over-represented nucleobase-modified DNA libraries and various selection conditions, capable of identifying high-affinity modified aptamers. Double partition followed by amplification of eluted sequences, NGS analysis and clustering provides fast identification of aptamer candidates. Screening of modified DNA libraries containing modified adenine and uracil nucleotides bearing hydrophobic aromatic phenyl and indole moieties results in development of an aptamer binding human insulin receptor with sub-nanomolar affinity and exquisite specificity. Cryo-EM structure reveals the importance of each aromatic modification, either in stabilizing the secondary structure or facilitating interactions with the protein surface. This approach addresses the main drawbacks of aptamer selection and has potential for high-throughput screening and accelerating the development of next-generation aptamers for diagnostics or therapeutics.
- 27 May 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessExpedient single-round selection of hyper-modified aptamer targeting insulin receptor from over-represented dually nucleobase-modified DNA libraries
Discovery of functional nucleic acids from randomized libraries typically relies on multiple, time-consuming iterative rounds of in vitro selection with low success rate. Here, we present a single-round selection strategy for rapid screening of multiple over-represented nucleobase-modified DNA libraries and various selection conditions, capable of identifying high-affinity modified aptamers. Double partition followed by amplification of eluted sequences, NGS analysis and clustering provides fast identification of aptamer candidates. Screening of modified DNA libraries containing modified adenine and uracil nucleotides bearing hydrophobic aromatic phenyl and indole moieties results in development of an aptamer binding human insulin receptor with sub-nanomolar affinity and exquisite specificity. Cryo-EM structure reveals the importance of each aromatic modification, either in stabilizing the secondary structure or facilitating interactions with the protein surface. This approach addresses the main drawbacks of aptamer selection and has potential for high-throughput screening and accelerating the development of next-generation aptamers for diagnostics or therapeutics.
- Open Access
- 15 May 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (20) , eaeb7558
An engineered insulin analog with dual insulin and IGF-1 receptor agonism and distinct signaling
Insulin and insulin-like growth factors (IGF-1 and IGF-2) regulate metabolism, growth, and development via related receptors. In contexts such as brain function or fetal development, coordinated signaling by all three hormones is essential. We report the engineering of [GluB10, D-HisB24, GlyB31, TyrB32]-insulin ( 1 Ins ), an analog with high affinity for IR-A, IR-B, and especially IGF-1R. 1 Ins binds IGF-1R ~1000-fold more strongly than native insulin, approaching IGF-1 levels. Cryo–electron microscopy structures reveal how minimal substitutions in 1 Ins enable effective binding to both IR-A and IGF-1R. In neuronal cells, 1 Ins robustly activates both IR and IGF-1R pathways, promotes survival, and exceeds native ligands in neuroprotective assays. In vivo, 1 Ins regulates glucose effectively in mice and rats. Phosphoproteomic profiling confirms dual pathway activation and identifies targets specific to 1 Ins . These findings demonstrate that rational design of dual-receptor agonists can yield potent, versatile ligands with therapeutic promise in metabolic control, neuroprotection, and regeneration.
- 15 May 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (20) , eaeb7558
Open AccessAn engineered insulin analog with dual insulin and IGF-1 receptor agonism and distinct signaling
Insulin and insulin-like growth factors (IGF-1 and IGF-2) regulate metabolism, growth, and development via related receptors. In contexts such as brain function or fetal development, coordinated signaling by all three hormones is essential. We report the engineering of [GluB10, D-HisB24, GlyB31, TyrB32]-insulin ( 1 Ins ), an analog with high affinity for IR-A, IR-B, and especially IGF-1R. 1 Ins binds IGF-1R ~1000-fold more strongly than native insulin, approaching IGF-1 levels. Cryo–electron microscopy structures reveal how minimal substitutions in 1 Ins enable effective binding to both IR-A and IGF-1R. In neuronal cells, 1 Ins robustly activates both IR and IGF-1R pathways, promotes survival, and exceeds native ligands in neuroprotective assays. In vivo, 1 Ins regulates glucose effectively in mice and rats. Phosphoproteomic profiling confirms dual pathway activation and identifies targets specific to 1 Ins . These findings demonstrate that rational design of dual-receptor agonists can yield potent, versatile ligands with therapeutic promise in metabolic control, neuroprotection, and regeneration.
- Open Access
- 14 November 2025
- Published by Springer Nature in Research Square
Over-Represented DNA Libraries Containing Two Hydrophobic (Het)aryl-Linked Nucleotides for Expedient Single-Round Selection of a Specific Aptamer Targeting Human Insulin Receptor
Discovery of functional nucleic acid ligands and catalytic motifs from a vast sequence space of randomized libraries is mostly based on time-consuming and demanding iterative rounds of in vitro selection. Here, we present a streamlined method for rapid identification of nucleobase-modified aptamers in a single selection round by combining chemically modified over-represented libraries, consecutive partition steps, and sequence abundance distribution analysis coupled with clustering. This approach generates distinct clusters of sequences, avoiding the need for massive screening of aptamer candidates. We demonstrated the proof-of-principle and effectiveness of the single-round selection approach resulting in a human insulin receptor aptamer, moreover, this method offers the expedient ability to screen multiple targets, various selection conditions, or differently modified libraries in a parallelized manner. The modified aptamer composed of two hydrophobic indole- and phenyl-linked nucleotides and two natural nucleotides exhibited picomolar binding affinity and exquisite specificity, capable of distinguishing subtle amino acid variations. Additionally, we determined the structure of the aptamer-receptor complex using cryo-electron microscopy, confirming the crucial role of hydrophobic aromatic modifications for the interactions of the aptamer with the target protein. These results highlight the synergistic effect of the components involved and demonstrate the capability of this methodology to generate highly potent and specific modified aptamers without tedious iterative selection rounds and extensive sequence space, thus accelerating aptamer discovery for therapeutic and diagnostic applications.
- 14 November 2025
- Published by Springer Nature in Research Square
Open AccessOver-Represented DNA Libraries Containing Two Hydrophobic (Het)aryl-Linked Nucleotides for Expedient Single-Round Selection of a Specific Aptamer Targeting Human Insulin Receptor
Discovery of functional nucleic acid ligands and catalytic motifs from a vast sequence space of randomized libraries is mostly based on time-consuming and demanding iterative rounds of in vitro selection. Here, we present a streamlined method for rapid identification of nucleobase-modified aptamers in a single selection round by combining chemically modified over-represented libraries, consecutive partition steps, and sequence abundance distribution analysis coupled with clustering. This approach generates distinct clusters of sequences, avoiding the need for massive screening of aptamer candidates. We demonstrated the proof-of-principle and effectiveness of the single-round selection approach resulting in a human insulin receptor aptamer, moreover, this method offers the expedient ability to screen multiple targets, various selection conditions, or differently modified libraries in a parallelized manner. The modified aptamer composed of two hydrophobic indole- and phenyl-linked nucleotides and two natural nucleotides exhibited picomolar binding affinity and exquisite specificity, capable of distinguishing subtle amino acid variations. Additionally, we determined the structure of the aptamer-receptor complex using cryo-electron microscopy, confirming the crucial role of hydrophobic aromatic modifications for the interactions of the aptamer with the target protein. These results highlight the synergistic effect of the components involved and demonstrate the capability of this methodology to generate highly potent and specific modified aptamers without tedious iterative selection rounds and extensive sequence space, thus accelerating aptamer discovery for therapeutic and diagnostic applications.
- Open Access
Antagonistic insulin mimetics lock the insulin receptor in an alternative apo-state
Despite significant advancements in high-resolution structural analysis of activated human insulin receptor (IR), the molecular mechanisms underlying its conformational plasticity that govern the transition from the apo state to the activated state are still not well understood. This leaves critical aspects of IR regulation unclear. Here, we reveal the mechanism by which the insulin mimetics Ada, Trim, and S661 fully inhibit the insulin receptor. The receptor is stabilized in a yet structurally un–described ∩–shaped conformation which is induced by antagonist binding between the L1 and FnIII-1’ domains. In contrast to insulin-bound IR structures, the α-CT helix is not observable in the ∩ conformation, and the membrane-proximal regions of the FnIII-3 domains are >10 nm apart, which prohibits transmembrane signal transduction and kinase domain activation. Analysis of apo-IR electron cryo-microscopy data indicates that the ∩-shaped state is one of several metastable apo-IR conformations. These findings underscore the intrinsic conformational dynamics of apo-IR and its role in integrating insulin binding and receptor activation.
Open AccessAntagonistic insulin mimetics lock the insulin receptor in an alternative apo-state
Despite significant advancements in high-resolution structural analysis of activated human insulin receptor (IR), the molecular mechanisms underlying its conformational plasticity that govern the transition from the apo state to the activated state are still not well understood. This leaves critical aspects of IR regulation unclear. Here, we reveal the mechanism by which the insulin mimetics Ada, Trim, and S661 fully inhibit the insulin receptor. The receptor is stabilized in a yet structurally un–described ∩–shaped conformation which is induced by antagonist binding between the L1 and FnIII-1’ domains. In contrast to insulin-bound IR structures, the α-CT helix is not observable in the ∩ conformation, and the membrane-proximal regions of the FnIII-3 domains are >10 nm apart, which prohibits transmembrane signal transduction and kinase domain activation. Analysis of apo-IR electron cryo-microscopy data indicates that the ∩-shaped state is one of several metastable apo-IR conformations. These findings underscore the intrinsic conformational dynamics of apo-IR and its role in integrating insulin binding and receptor activation.
- Open Access
- 8 November 2023
- Published by The Royal Society in Open Biology
- Vol. 13 (11) , 230142
Insulin receptor Arg717 and IGF-1 receptor Arg704 play a key role in ligand binding and in receptor activation
The insulin receptor (IR, with its isoforms IR-A and IR-B) and the insulin-like growth factor 1 receptor (IGF-1R) are related tyrosine kinase receptors. Recently, the portfolio of solved hormone–receptor structures has grown extensively thanks to advancements in cryo-electron microscopy. However, the dynamics of how these receptors transition between their inactive and active state are yet to be fully understood. The C-terminal part of the alpha subunit ( α CT) of the receptors is indispensable for the formation of the hormone-binding site. We mutated the α CT residues Arg717 and His710 of IR-A and Arg704 and His697 of IGF-1R. We then measured the saturation binding curves of ligands on the mutated receptors and their ability to become activated. Mutations of Arg704 and His697 to Ala in IGF-1R decreased the binding of IGF-1. Moreover, the number of binding sites for IGF-1 on the His697 IGF-1R mutant was reduced to one-half, demonstrating the presence of two binding sites. Both mutations of Arg717 and His710 to Ala in IR-A inactivated the receptor. We have proved that Arg717 is important for the binding of insulin to its receptor, which suggests that Arg717 is a key residue for the transition to the active conformation.
- 8 November 2023
- Published by The Royal Society in Open Biology
- Vol. 13 (11) , 230142
Open AccessInsulin receptor Arg717 and IGF-1 receptor Arg704 play a key role in ligand binding and in receptor activation
The insulin receptor (IR, with its isoforms IR-A and IR-B) and the insulin-like growth factor 1 receptor (IGF-1R) are related tyrosine kinase receptors. Recently, the portfolio of solved hormone–receptor structures has grown extensively thanks to advancements in cryo-electron microscopy. However, the dynamics of how these receptors transition between their inactive and active state are yet to be fully understood. The C-terminal part of the alpha subunit ( α CT) of the receptors is indispensable for the formation of the hormone-binding site. We mutated the α CT residues Arg717 and His710 of IR-A and Arg704 and His697 of IGF-1R. We then measured the saturation binding curves of ligands on the mutated receptors and their ability to become activated. Mutations of Arg704 and His697 to Ala in IGF-1R decreased the binding of IGF-1. Moreover, the number of binding sites for IGF-1 on the His697 IGF-1R mutant was reduced to one-half, demonstrating the presence of two binding sites. Both mutations of Arg717 and His710 to Ala in IR-A inactivated the receptor. We have proved that Arg717 is important for the binding of insulin to its receptor, which suggests that Arg717 is a key residue for the transition to the active conformation.
- Open Access
Non-glycosylated IGF2 prohormones are more mitogenic than native IGF2
Insulin-like Growth Factor-2 (IGF2) is important for the regulation of human embryonic growth and development, and for adults’ physiology. Incorrect processing of the IGF2 precursor, pro-IGF2(156), leads to the formation of two IGF2 proforms, big-IGF2(87) and big-IGF2(104). Unprocessed and mainly non-glycosylated IGF2 proforms are found at abnormally high levels in certain diseases, but their mode of action is still unclear. Here, we found that pro-IGF2(156) has the lowest ability to form its inactivating complexes with IGF-Binding Proteins and has higher proliferative properties in cells than IGF2 and other IGF prohormones. We also showed that big-IGF2(104) has a seven-fold higher binding affinity for the IGF2 receptor than IGF2, and that pro-IGF2(87) binds and activates specific receptors and stimulates cell growth similarly to the mature IGF2. The properties of these pro-IGF2 forms, especially of pro-IGF2(156) and big-IGF2(104), indicate them as hormones that may be associated with human diseases related to the accumulation of IGF-2 proforms in the circulation.
Open AccessNon-glycosylated IGF2 prohormones are more mitogenic than native IGF2
Insulin-like Growth Factor-2 (IGF2) is important for the regulation of human embryonic growth and development, and for adults’ physiology. Incorrect processing of the IGF2 precursor, pro-IGF2(156), leads to the formation of two IGF2 proforms, big-IGF2(87) and big-IGF2(104). Unprocessed and mainly non-glycosylated IGF2 proforms are found at abnormally high levels in certain diseases, but their mode of action is still unclear. Here, we found that pro-IGF2(156) has the lowest ability to form its inactivating complexes with IGF-Binding Proteins and has higher proliferative properties in cells than IGF2 and other IGF prohormones. We also showed that big-IGF2(104) has a seven-fold higher binding affinity for the IGF2 receptor than IGF2, and that pro-IGF2(87) binds and activates specific receptors and stimulates cell growth similarly to the mature IGF2. The properties of these pro-IGF2 forms, especially of pro-IGF2(156) and big-IGF2(104), indicate them as hormones that may be associated with human diseases related to the accumulation of IGF-2 proforms in the circulation.
- Open Access
- 21 December 2022
- Published by The Royal Society in Open Biology
- Vol. 12 (12) , 220322
Characterization of insulin crystalline form in isolated β-cell secretory granules
Insulin is stored in vivo inside the pancreatic β-cell insulin secretory granules. In vitro studies have led to an assumption that high insulin and Zn 2+ concentrations inside the pancreatic β-cell insulin secretory granules should promote insulin crystalline state in the form of Zn 2+ -stabilized hexamers. Electron microscopic images of thin sections of the pancreatic β-cells often show a dense, regular pattern core, suggesting the presence of insulin crystals. However, the structural features of the storage forms of insulin in native preparations of secretory granules are unknown, because of their small size, fragile character and difficult handling. We isolated and investigated the secretory granules from MIN6 cells under near-native conditions, using cryo-electron microscopic (Cryo-EM) techniques. The analysis of these data from multiple intra -granular crystals revealed two different rhomboidal crystal lattices. The minor lattice has unit cell parameters ( a ≃ b ≃ 84.0 Å, c ≃ 35.2 Å), similar to in vitro crystallized human 4Zn 2+ -insulin hexamer, whereas the largely prevalent unit cell has more than double c -axis ( a ≃ b ≃ c ≃ 96.5 Å) that probably corresponds to two or three insulin hexamers in the asymmetric unit. Our experimental data show that insulin can be present in pancreatic MIN 6 cell granules in a microcrystalline form, probably consisting of 4Zn 2+ -hexamers of this hormone.
- 21 December 2022
- Published by The Royal Society in Open Biology
- Vol. 12 (12) , 220322
Open AccessCharacterization of insulin crystalline form in isolated β-cell secretory granules
Insulin is stored in vivo inside the pancreatic β-cell insulin secretory granules. In vitro studies have led to an assumption that high insulin and Zn 2+ concentrations inside the pancreatic β-cell insulin secretory granules should promote insulin crystalline state in the form of Zn 2+ -stabilized hexamers. Electron microscopic images of thin sections of the pancreatic β-cells often show a dense, regular pattern core, suggesting the presence of insulin crystals. However, the structural features of the storage forms of insulin in native preparations of secretory granules are unknown, because of their small size, fragile character and difficult handling. We isolated and investigated the secretory granules from MIN6 cells under near-native conditions, using cryo-electron microscopic (Cryo-EM) techniques. The analysis of these data from multiple intra -granular crystals revealed two different rhomboidal crystal lattices. The minor lattice has unit cell parameters ( a ≃ b ≃ 84.0 Å, c ≃ 35.2 Å), similar to in vitro crystallized human 4Zn 2+ -insulin hexamer, whereas the largely prevalent unit cell has more than double c -axis ( a ≃ b ≃ c ≃ 96.5 Å) that probably corresponds to two or three insulin hexamers in the asymmetric unit. Our experimental data show that insulin can be present in pancreatic MIN 6 cell granules in a microcrystalline form, probably consisting of 4Zn 2+ -hexamers of this hormone.
- Open Access
- 1 October 2020
- Published by The Royal Society in Open Biology
- Vol. 10 (10) , 200137
The efficiency of insulin production and its content in insulin-expressing model β-cells correlate with their Zn2+ levels
Insulin is produced and stored inside the pancreatic β-cell secretory granules, where it is assumed to form Zn2+-stabilized oligomers. However, the actual storage forms of this hormone and the impact of zinc ions on insulin production in vivo are not known. Our initial X-ray fluorescence experiment on granules from native Langerhans islets and insulinoma-derived INS-1E cells revealed a considerable difference in the zinc content. This led our further investigation to evaluate the impact of the intra-granular Zn2+ levels on the production and storage of insulin in different model β-cells. Here, we systematically compared zinc and insulin contents in the permanent INS-1E and BRIN-BD11 β-cells and in the native rat pancreatic islets by flow cytometry, confocal microscopy, immunoblotting, specific messenger RNA (mRNA) and total insulin analysis. These studies revealed an impaired insulin production in the permanent β-cell lines with the diminished intracellular zinc content. The drop in insulin and Zn2+ levels was paralleled by a lower expression of ZnT8 zinc transporter mRNA and hampered proinsulin processing/folding in both permanent cell lines. To summarize, we showed that the disruption of zinc homeostasis in the model β-cells correlated with their impaired insulin and ZnT8 production. This indicates a need for in-depth fundamental research about the role of zinc in insulin production and storage.
- 1 October 2020
- Published by The Royal Society in Open Biology
- Vol. 10 (10) , 200137
Open AccessThe efficiency of insulin production and its content in insulin-expressing model β-cells correlate with their Zn2+ levels
Insulin is produced and stored inside the pancreatic β-cell secretory granules, where it is assumed to form Zn2+-stabilized oligomers. However, the actual storage forms of this hormone and the impact of zinc ions on insulin production in vivo are not known. Our initial X-ray fluorescence experiment on granules from native Langerhans islets and insulinoma-derived INS-1E cells revealed a considerable difference in the zinc content. This led our further investigation to evaluate the impact of the intra-granular Zn2+ levels on the production and storage of insulin in different model β-cells. Here, we systematically compared zinc and insulin contents in the permanent INS-1E and BRIN-BD11 β-cells and in the native rat pancreatic islets by flow cytometry, confocal microscopy, immunoblotting, specific messenger RNA (mRNA) and total insulin analysis. These studies revealed an impaired insulin production in the permanent β-cell lines with the diminished intracellular zinc content. The drop in insulin and Zn2+ levels was paralleled by a lower expression of ZnT8 zinc transporter mRNA and hampered proinsulin processing/folding in both permanent cell lines. To summarize, we showed that the disruption of zinc homeostasis in the model β-cells correlated with their impaired insulin and ZnT8 production. This indicates a need for in-depth fundamental research about the role of zinc in insulin production and storage.